Evidence for a reduced chemokine response in the lungs of beige mice infected with Mycobacterium avium

Immunology

Volumn 90, Issue 4, 1997, Pages 600-606

  Florido, M ^a   Appelberg, R ^a   Orme, I M ^b   Cooper, A M ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GANGLIOSIDE GM1;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; LUNG; MALE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; VIRULENCE;

EID: 0030899356     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00206.x     Document Type: Article

References (37)

1. HAWKINS C.C., GOLD J.W.M., WHIMBLEY E. et al. (1986) Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 105, 184.
2. HORSBURGH C.R. (1991) Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 324, 1332.
3. YOUNG L.S., INDERLIED C.B., BERLIN O.G. & GOTTLIEB M.S. (1986) Mycobacterial infection in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev Infect Dis 8, 1024.
4. PEDROSA J., FLÓRIDO M., KUNZE Z.M. et al. (1994) Characterization of the virulence of Mycobacterium avium isolates in mice. Clin Exp Immunol 98, 210.
5. APPELBERG R. & SARMENTO A.M. (1990) The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice. Clin Exp Immunol 80, 324.
6. CASTRO A.G., MINÓPRIO P. & APPELBERG R. (1995) The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice. Immunology 85, 556.
7. ORME I.M., STOKES R.W. & COLLINS F.M. (1986) Genetic control of natural resistance to nontuberculous mycobacterial infections in mice. Infect Immun 54, 56.
8. BACA M.E., MOWAT A.M. & PARROT D.M.V. (1989) Immunological studies of NK cell-deficient beige mice. Immunology 66, 131.
9. BARBOSA M.D.F.S., NGUYEN Q.A., TCHERNEV V.T. et al. (1996) Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 382, 262.
10. MAHONEY K.H., MORSE S.S. & MORAHAN P.S. (1980) Macrophage functions in beige (Chédiak-Higashi Syndrome) mice. Cancer Res 40, 3934.
11. OLIVER C. & ESSNER E. (1975) Formation of anomalous lysosomes in monocytes, neutrophils and eosinophils from bone marrow of mice with Chédiak-Higashi Syndrome. Lab Invest 32, 17.
12. RODER J.C., LOHMANN-MATTHES M., DOMZIG W. & WIGZELL H. (1979) The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J Immunol 123, 2174.
13. SAXENA R.K., SAXENA Q.B. & ADLER W.H. (1982) Defective T-cell response in beige mutant mice. Nature 295, 240.
14. BERMUDEZ L.E., KOLONOSKY P., YOUNG L.S. & INDERLIED C.B. (1994) Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection. Antimicrob Agents Chemother 38, 1844.
15. CYNAMON M.H. & KLEMENS S.P. (1992) Activity of azithromycin against Mycobacterium avium complex infection in beige mice. Antimicrob Agents Chemother 36, 1611.
16. FURNEY S.K., ROBERTS A.D. & ORME I.M. (1990) Effect of rifabutin on disseminated Mycobacterium avium infections in thymectomized, CD4 T-cell-deficient mice. Antimicrob Agents Chemother 34, 1629.
17. GANGADHARAM P.R.J. & PARIKH K. (1992) In vivo activity of streptomycin and clofazimine against established infections of Mycobacterium avium complex in beige mice. J Antimicrob Chemother 30, 833.
18. GANGADHARAM P.R.J., PERUMAL V.K., FAHRI D.C. & LABRECQUE J. (1989) The beige mouse model for Mycobacterium avium complex (MAC) disease: optimal conditions for the host and parasite. Tubercle 70, 257.
19. JI B., LOUNIS N., TRUFFOT-PERNOT C. & GROSSET J.H. (1994) Effectiveness of various antimicrobial agents against Mycobacterium avium complex in beige mouse model. Antimicrob Agent Chemother 38, 2521.
20. KLEMENS S.P., DESTEFANO M.S. & CYNAMON M.H. (1992) Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. Antimicrob Agents Chemother 36, 2413.
21. BERTRAM M., INDERLIED C.B., YADEGAR S., KOLONOSKY P., YAMADA J.K. & YOUNG L.S. (1986) Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex. J Infect Dis 154, 194.
22. GANGADHARAM P.R.J. (1995) Beige mouse model for Mycobacterium avium complex disease. Antimicrob Agents Chemother 39, 1647.
23. GANGADHARAM R.J., PERUMAL V.K., PARIKH K. et al. (1989) Susceptibility of beige mice to Mycobacterium avium complex infections by different routes of challenge. Am Rev Respir Dis 139, 1098.
24. ORME I.M., FURNEY S.K. & ROBERTS A.D. (1992) Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine retroviruses. Infect Immun 60, 4747.
25. HARSHAN K.V. & GANGADHARAM P.R.J. (1991) In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect Immun 59, 2818.
26. APPELBERG R. (1992) Interferon-gamma and macrophage inflammatory proteins (MIP)-1 and -2 are involved in the regulation of the T cell-dependent chronic peritoneal neutrophilia of mice infected with mycobacteria. Clin Exp Immunol 89, 269.
27. APPELBERG R., CASTRO A.G., GOMES S., PEDROSA J. & SILVA M.T. (1995) Susceptibility of beige mice to Mycobacterium avium: role of neutrophils. Infect Immun 63, 3381.
28. BELISLE J.T., KLACZKIEWICZ K., BRENNAN P.J., JACOBS W.R. & INAMINE J.M. (1993) Rough morphological variants of Mycobacterium avium. Characterization of genomic deletions resulting in the loss of glycopeptidolipid expression. J Biol Chem 268, 10510.
29. COOPER A.M., CALLAHAN J.E., GRIFFIN J.P., ROBERTS A.D. & ORME I.M. (1995) Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis. Infect Immun 63, 3259.
30. APPELBERG R., CASTRO A.G., PEDROSA J., SILVA R.A., ORME I.M. & MINÓPRIO P. (1994) Role of gamma interferon and tumour necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect Immun 62, 3962.
31. COOPER A.M., DALTON D.K., STEWART T.A., GRIFFIN J.P., RUSSELL D.G. & ORME I.M. (1993) Disseminated tuberculosis in gamma interferon gene-disrupted mice. J Exp Med 178, 2243.
32. RHOADES E.R., COOPER A.M. & ORME I.M. (1995) Chemokine response in mice infected with Mycobacterium tuberculosis. Infect Immun 63, 3871.
33. SAUNDERS B.M. & CHEERS C. (1995) Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon. Infect Immun 63, 2282.
34. APPELBERG R., SARMENTO A. & CASTRO A.G. (1995) Tumour necrosis factor-alpha (TNFα) in the host resistance to mycobacteria of distinct virulence. Clin Exp Immunol 101, 308.
35. BERMUDEZ L.E. & YOUNG L.S. (1988) Tumor necrosis factor, alone or in combination with IL2, but not IFNγ, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 140, 3006.
36. DENIS M. (1991) Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria. Clin Exp Immunol 83, 466.
37. SARMENTO A.M. & APPELBERG R. (1995) Relationship between virulence of Mycobacterium avium strains and induction of tumour necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages. Infect Immun 63, 3759.